Idiopathic pulmonary hypertension

Known as: pulmonary primary hypertension, Primary pulmonary hypertension, Idiopathic Pulmonary Arterial Hypertension 
Increased blood pressure in the arteries of the lungs; the etiology is unknown.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Current guidelines for the treatment of patients with idiopathic pulmonary arterial hypertension (IPAH) recommend basing… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Vascular remodeling in idiopathic pulmonary arterial hypertension (IPAH) involves hyperproliferative and apoptosis-resistant… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Idiopathic pulmonary arterial hypertension (IPAH) is characterized by plexiform vascular lesions, which are hypothesized to arise… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
AIMS Data on long-term efficacy of bosentan in unselected idiopathic pulmonary arterial hypertension (IPAH) patients are lacking… (More)
  • table 1
  • figure 1
  • table 2
  • table 4
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Addition of inhaled iloprost to bosentan may have beneficial effects in patients with idiopathic pulmonary arterial hypertension… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Characteristics of patients with idiopathic pulmonary arterial hypertension (IPAH) who benefit from long-term calcium… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE We explored the potential role of the endogenous NO synthase inhibitor asymmetrical dimethylarginine (ADMA) in patients… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Pulmonary vascular medial hypertrophy caused by excessive pulmonary artery smooth muscle cell (PASMC) proliferation is a major… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 5
Is this relevant?
Highly Cited
2004
Highly Cited
2004
It has been proposed that targeted treatments should be combined for patients with idiopathic pulmonary arterial hypertension… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Treatment for idiopathic pulmonary arterial hypertension in children includes calcium channel blockade (CCB) for acute… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?